Gut Microbiota: A Potential Target for Cancer Interventions.

Area of Science:

• Microbiology
• Oncology
• Immunology

Background:

• The gut microbiota significantly impacts human health, influencing metabolism and immune responses.
• Gut dysbiosis (microbial imbalance) is linked to various diseases, including cancer.
• The gut microbiome affects cancer initiation, progression, and host responses.

Purpose of the Study:

• To review the latest research on the intestinal microbiome and cancer.
• To explore the mechanisms by which the gut microbiota influences cancer.
• To discuss the impact of the gut microbiota on cancer treatment efficacy and toxicity.

Main Methods:

• Literature review of scientific articles on gut microbiota and cancer.
• Analysis of studies investigating the role of microbial metabolites and immune interactions.
• Examination of research on microbiome-targeted cancer therapies.

Main Results:

• The gut microbiota contributes to cancer by damaging DNA, promoting inflammation, and modulating immune surveillance.
• Microbial composition impacts the effectiveness and side effects of chemotherapy, radiotherapy, and immunotherapy.
• Fine-tuning the gut microbiota shows potential for enhancing anti-cancer treatments.

Conclusions:

• The gut microbiome is a critical factor in cancer development and treatment.
• Targeting the gut microbiota presents promising avenues for novel cancer detection and therapeutic strategies.
• Further research is needed to fully elucidate the complex interactions between the microbiome and cancer.